Mirae Asset Global Investments
MAZE

Mirae Asset Global Investments’s Maze Therapeutics MAZE Stock Holding History

Mirae Asset Global Investments’s Portfolio MAZE Stock Details MAZE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.9K Sell
2,475
-35
-1% -$917 ﹤0.01% 1301
2026
Q1 		$74.9K Buy
2,510
+172
+7% +$7.59K ﹤0.01% 1226
2025
Q4 		$96.9K Buy
+2,338
New +$80.4K ﹤0.01% 1259

Other funds holding MAZE

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
FWP
Falcon Wealth Planning Ontario, California $1.58B AUM 20.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
TM
Torren Management San Diego, California $197M AUM
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

Mirae Asset Global Investments's MAZE Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Maze Therapeutics (MAZE) stake by 1.4% in Q2 2026, selling an estimated $917 and leaving 2,475 shares worth $73.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1301.

Mirae Asset Global Investments first reported a position in MAZE in Q4 2025 and has held it in 3 quarters since. The position peaked at $96.9K in Q4 2025. 13 funds tracked by Wall St. Rank hold MAZE as of Q2 2026.

  • Mirae Asset Global Investments held 2,475 shares of Maze Therapeutics worth $73.9K as of Q2 2026.
  • Mirae Asset Global Investments sold 35 Maze Therapeutics shares in Q2 2026, an estimated $917.
  • Maze Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1301 holding.
  • Mirae Asset Global Investments first reported a position in Maze Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Mirae Asset Global Investments's Maze Therapeutics position peaked at $96.9K in Q4 2025.
  • 13 funds tracked by Wall St. Rank held Maze Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.